BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
4/29/16 Acadia (ACAD) Nuplazid for Parkinson's Disease (PD) Subscribers Only Subscribers Only Subscribers Only
4/29/16 Advanced Accelerator Applications (AAAP) Lutathera for Neuroendocrine Tumors (NET) Subscribers Only Subscribers Only Subscribers Only
4/29/16 Teva (TEVA) ProAir RespiClick for Asthma Subscribers Only Subscribers Only Subscribers Only
4/28/16 Adamas Pharmaceuticals (ADMS) Nurelin for Levodopa-Induced Dyskinesia Subscribers Only Subscribers Only Subscribers Only
4/28/16 Novo Nordisk (NVO) Semaglutide for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
04/29/16 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
04/29/16 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
05/01/16 Subscribers Only Subscribers Only Trial Data - Updated Results
05/01/16 Subscribers Only Subscribers Only Trial Data - Updated Results
05/01/16 Subscribers Only Subscribers Only Patent - Expiration of 30-Month Stay